Renewal of the sales partnership in the blood coagulation field with Siemens Healthcare Diagnostics
First written in FY2017-Q1. 3 of 6 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2023.
No other company in this theme has enough history to compare yet.
- FY2023AdvancedAnnual report
「We entered into a global OEM agreement with Siemens Healthcare Diagnostics in the field of blood coagulation testing. Under this agreement, the two companies will supply each other with OEM equipment and reagents for blood coagulation testing and sell them globally under their respective brands.」
The former reciprocal supply, sales and servicing partnership was expanded into a reciprocal global OEM supply agreement running from 1 March 2023 through 28 February 2038. - FY2021AdvancedAnnual report
「Global supply, sales and servicing of products related to blood coagulation testing」
The agreement with Siemens Healthcare Diagnostics was renewed from 1 February 2021 through 31 December 2023, and the Company is strengthening sales as part of a global alliance that includes reviewing the products handled and the territories covered. - FY2018RestatedAnnual report
「Partnership covering the reciprocal supply, sales and servicing of blood coagulation analyzers and reagents」
The Company disclosed that the term of its partnership with Siemens Healthcare Diagnostics in the blood coagulation field runs through 31 December 2021. - FY2018-Q1AdvancedAnnual report
「On 9 May 2017, during the first quarter of the consolidated accounting period, the Company renewed its sales partnership agreement with Siemens Healthcare Diagnostics after changing the contract term. The partnership covers the reciprocal supply, sales and servicing of blood coagulation analyzers and reagents.」
The reciprocal supply, sales and servicing partnership in the blood coagulation field was renewed, with the contract term running through 31 December 2021. The contract expiration date was extended from 31 December 2020, as disclosed previously. - FY2017RestatedAnnual report
「Partnership covering the reciprocal supply, sales and servicing of blood coagulation analyzers and reagents」
The Company disclosed a reciprocal supply, sales and servicing partnership with Siemens Healthcare Diagnostics in the blood coagulation field, under a contract running through 31 December 2020. - FY2017-Q1First statedAnnual report
「On 12 April 2016, during the first quarter of the consolidated accounting period, the Company renewed its sales partnership agreement with Siemens Healthcare Diagnostics after changing the contract term. The partnership covers the reciprocal supply, sales and servicing of blood coagulation analyzers and reagents.」
The partnership covering the reciprocal supply, sales and servicing of blood coagulation analyzers and reagents was renewed through 31 December 2020.